Pre-Open Stock Movers 12/30: (NAKD) (KR) (TSCO) Higher; (BIIB) (DIDI) (MDGL) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
Yearly Drug Price Changes by Biogen (BIIB), Gilead (GILD), Regeneron (REGN) and Vertex (VRTX) - Truist
January 3, 2022 5:39 AM ESTTruist analyst Robyn Karnauskas recaps recently announced drug price changes by Biogen (NASDAQ: BIIB), Regeneron (NASDAQ: REGN), Vertex Pharma (NASDAQ: VRTX), and Gilead Sciences (NASDAQ:... More
Tesla (TSLA) PT Raised to $295 at JPMorgan, Reiterates Underweight
January 3, 2022 2:13 AM ESTJPMorgan analyst Ryan Brinkman raised the price target on Tesla (NASDAQ: TSLA) to $295.00 (from $250.00) while maintaining a Underweight rating.
The analyst comments "Our Underweight rating considers notable investment positives, including a highly differentiated business model, appealing product portfolio, and leading-edge technology, which... More
No Negative in Madrigal Pharma's (MDGL) Topline Data Delay - H. C. Wainwright
December 30, 2021 11:02 AM ESTEarlier today, Madrigal Pharma (NASDAQ: MDGL) announced delay in release... More



